Description: Numares Health uses AI-enabled technology to develop novel diagnostics for conditions stemming from metabolic dysfunction, including chronic kidney, cardiovascular and liver diseases. Numares develops advanced tests for diagnosis and measurement of disease progression by applying machine learning to metabolomics, evaluating multiple biomarkers alone and in combination. The company developed the FDA-cleared AXINON® System that makes next-generation use of nuclear magnetic resonance spectroscopy for this biom
ai (10440) innovation (8493) risk (1219) spectroscopy (138) nmr (124) assay (53) biomarkers (44) biomarker (44) metabolomics (43) metabolome (4)
From a single serum sample, we quantify multiple biomarkers — known and newly discovered. Advanced. Automated. Affordable.
Now with FDA clearance, this is our core technology platform, incorporating diagnostic testing algorithms into nuclear magnetic resonance (NMR) spectroscopy. It's the first modular software-based system for clinical diagnostics.
Learn more